명상도서관
Feasibility of the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program for symptom improvement among breast cancer survivors
자세히보기

- 자료유형학술지논문
- 저자명Lengacher, C. A.,Reich, R. R.,Ramesar, S.,Alinat, C. B.,Moscoso, M.,Cousin, L.,Marino, V. R.,Elias, M. N.,Paterson, C. L.,Pleasant, M. L.
- 학회/출판사/기관명John Wiley & Sons, Ltd
- 출판년도2018
- 언어영어
- 학술지명/학위논문주기PSYCHOONCOLOGY
- 발행사항Vol.27No.2[2018]_x000D_
- ISBN/ISSN1057-9249
- 소개/요약Objective: The purpose of this pilot study was to test the feasibility of delivering the mobile Mindfulness-Based Stress Reduction for Breast Cancer (mMBSR(BC)) program using an iPad and to evaluate its impact on symptom improvement. Methods: A single group, pre-posttest design was implemented among female stages 0-III breast cancer survivors (BCS) who completed treatment. Data were collected at baseline and week 6 on measures of psychological and physical symptoms and quality of life. The mMBSR(BC) program is a standardized, stress-reducing intervention that combines sitting and walking meditation, body scan and yoga and is designed to deliver weekly 2-hour sessions for 6 weeks using an iPad. Results: The mean age of the 15 enrolled BCS was 57 years; one participant was non-Hispanic Black, and 14 were non-Hispanic White. Of the 13 who completed the study, there were significant improvements from baseline to 6 weeks post-mMBSR(BC) in psychological and physical symptoms of depression, state anxiety, stress, fear of recurrence, sleep quality, fatigue and quality of life (p's < 0.05). Effect sizes for improvements of multiple symptoms ranged from medium to large. Conclusions: These results provide preliminary support that the mMBSR(BC) program may be feasible and acceptable, showing a clinical impact on decreasing psychological and physical symptoms. This mobile-based program offers a delivery of a standardized MBSR(BC) intervention to BCS that is convenient for their own schedule while decreasing symptom burden in the survivorship phase after treatment for breast cancer.
TOP